Regeneron R&D expenses 2016-2023
Regeneron Pharmaceuticals spent over 4.4 billion U.S. dollars on research and development in 2023, up from 3.6 billion U.S. dollars in the preceding year. The statistic illustrates the annual research and development expenses for Regeneron Pharmaceuticals between 2016 and 2023. Regeneron is a U.S-based global biotech company with headquarters in Tarrytown, New York.